Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

‘Lab on a Chip’ Allows Early Diagnosis of Disease

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Philips Elevate Plus Gains FDA Clearance...

Philips announced that it has obtained FDA clearance for...

Smith+Nephew Launches Next-Generation LEAF Platform for...

Smith+Nephew has announced the launch of its next-generation LEAF...

Multimodal AI Advancing Next Generation Clinical...

Multimodal AI is advancing next-generation clinical workflows by combining data from medical imaging, electronic health records, and genomic profiles into a unified decision-making framework. This enables more accurate diagnoses, personalized treatments, and streamlined clinical operations, improving both healthcare efficiency and patient outcomes.
Professor Christofer Toumazou, at the Imperial College in London, has invented a‘lab on a chip’ technology that can examine a person’s DNA within about 30 minutes and diagnose certain diseases and also discover if a person has a predisposition.
This new technology termed as a major breakthrough in preventive medicine by diagnosing infectious or inherited diseases in the early stages before they’ve been identified normally. This could allow treating patients and prescribing appropriate drugs immediately.
The technology deals with pH changes as DNA strands combine together, allowing genetic sequences to be read rapidly and directly at the point of need.
Silicon transistors used in lab-on-a-chip device help identify DNA and RNA, amplifying and detecting DNA and other biomolecules using pH measurement. This is less expensive and faster than other DNA and RNA analysis methods and equipment currently available in the market.
This new microchip, which has won the European Inventor Award 2014 in the category of research, will be available in Europe within three years and later in the United States. Prototypes of the microchip should be available in early 2016.

Hospital & Healthcare Management brings together the global healthcare industry — from hospital administrators and clinical directors to health technology innovators and policy leaders — through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium healthcare industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global hospital and healthcare management value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.
MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

Philips Elevate Plus Gains FDA Clearance for AI Ultrasound

Philips announced that it has obtained FDA clearance for...

Smith+Nephew Launches Next-Generation LEAF Platform for Remote Patient Monitoring

Smith+Nephew has announced the launch of its next-generation LEAF...

Multimodal AI Advancing Next Generation Clinical Workflows

Multimodal AI is advancing next-generation clinical workflows by combining data from medical imaging, electronic health records, and genomic profiles into a unified decision-making framework. This enables more accurate diagnoses, personalized treatments, and streamlined clinical operations, improving both healthcare efficiency and patient outcomes.

Digital Biomarkers Enhancing Continuous Health Assessment

Digital biomarkers are enhancing continuous health assessment by using data from wearables, smartphones, and connected devices to monitor patients in real time. This approach provides deeper insights into health trends, supports earlier interventions, and improves preventive care and chronic disease management beyond traditional clinical visits.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »